Avita Medical | Betriebsergebnis



Operating Profit Veränderung Datum
Adcock Ingram Holdings ZAR 487.33M 8.25M 2024-12
Celltrion KRW 242.47B 94.87B 2025-06
Clinuvel Pharmaceuticals AUD 39.05M 21.49M 2024-06
Cochlear AUD 274.6M 54.5M 2024-12
CSL USD 1.98B 778M 2024-12
Cspc Pharmaceutical CNY 1.79B 940.51M 2025-03
Dianthus Therapeutics USD -34927000 3.01M 2025-06
Divis Laboratories Ltd 6.17B 1.62B 2025-06
Kangmei Pharma CNY 16.43M 3.34M 2025-06
Knight Therapeutics CAD 3.2M 1.29M 2024-09
Laboratorios Farma EUR 27.37M 95.7M 2025-06
Malin Corporation EUR -1100000 400K 2024-12
Mayne Pharma AUD -3300000 15.67M 2024-06
Medical Developments International AUD 182K 20.42M 2024-12
Nanosonics AUD 8.7M 6.12M 2024-12
Neuren Pharmaceuticals AUD 176.69M 166.79M 2024-12
Organigram Holdings CAD -2100000 9.2M 2025-06
Pacific Edge NZD -15314000 7.45M 2024-09
Paradigm Biopharmaceuticals AUD -5930700 3.79M 2024-12
Pharma Mar EUR 24.11M 27.19M 2025-06
Polynovo AUD 513K 902K 2024-06
PYC Therapeutics AUD -25891160 14.18M 2024-12
Qiagen NV USD 135.97M 10.81M 2025-06
Ramsay Health Care AUD 200M 285.4M 2024-12
ResMed USD 456.57M 39.33M 2025-06
Sartorius EUR 161.8M 24.4M 2025-06
Sino Biopharmaceutical CNY 1.33B 2.53B 2024-12
Telix Pharmaceuticals AUD 17.72M 24.27M 2024-12
Tilray USD -42218000 5.65M 2024-11
Zz Pientze Pharmaceu 553.87M 632.12M 2025-06


Avita Medical Betriebsergebnis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.